Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ruth B Etzioni"'
Autor:
Kelvin A. Moses, Preston C. Sprenkle, Clinton Bahler, Geoffrey Box, Sigrid V. Carlsson, William J. Catalona, Douglas M. Dahl, Marc Dall’Era, John W. Davis, Bettina F. Drake, Jonathan I. Epstein, Ruth B. Etzioni, Thomas A. Farrington, Isla P. Garraway, David Jarrard, Eric Kauffman, Deborah Kaye, Adam S. Kibel, Chad A. LaGrange, Paul Maroni, Lee Ponsky, Brian Reys, Simpa S. Salami, Alejandro Sanchez, Tyler M. Seibert, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Mark D. Tyson, Neha Vapiwala, Robert Wake, Samuel Washington, Alice Yu, Bertram Yuh, Ryan A. Berardi, Deborah A. Freedman-Cass
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:236-246
The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guideline
Autor:
Fady Ghali, Yibai Zhao, Devin Patel, Teresa Jewell, Evan Y. Yu, Petros Grivas, R. Bruce Montgomery, John L. Gore, Ruth B. Etzioni, Jonathan L. Wright
Publikováno v:
European Urology Open Science. 47:58-64
Surrogate endpoints (SEs), such as progression-free survival (PFS) and objective response rate (ORR), are frequently used in clinical trials. The relationship between SEs and overall survival (OS) has not been well described in metastatic urothelial
Autor:
Marc D Ryser, Jane Lange, Lurdes Inoue, Ellen S O'Meara, Charlotte Gard, Diana L Miglioretti, Jean-Luc Bulliard, Andrew F Brouwer, E. Shelley Hwang, Ruth B Etzioni
Publikováno v:
Cancer Research. 82:GS4-06
Background. Breast cancer screening is subject to overdiagnosis, that is the mammographic detection of cancers that would not become symptomatic or otherwise cause harm in the absence of screening. The risk of overdiagnosis associated with screening
Autor:
Charlotte Elizabeth Coles, Benjamin O Anderson, David Cameron, Fatima Cardoso, Richard Horton, Felicia Marie Knaul, Miriam Mutebi, Naomi Lee, Jean E Abraham, Fabrice André, Carlos H Barrios, Judith M Bliss, Judy C Boughey, David A Cameron, Fatima V Cardoso, Lisa A Carey, Sanjoy Chatterjee, Charlotte E Coles, Jack Cuzick, Dorothy Du Plooy, Prudence A Francis, Julie R Gralow, Reshma Jagsi, Felicia M Knaul, Fei Ma, Ritse M Mann, Stuart A McIntosh, Shirley A Mertz, Funmi Olopade, Kelly-Anne Phillips, Philip M Poortmans, Tanja Spanic, Dingle Spence, Hilary Stobart, Fraser WF Symmans, Cynthia Villarreal-Garza, Cheng-Har Yip, Maya J Bienz, Lynsey M Drewett, Alex Fulton, Dharrnesha Inbah Rajah, Farasat Kazmi, Jeffrey Rubasingham, Mareike Thompson, Valentina Vargas, Hector Arreola, Raj A Badwe, Renzo JC Calderon Anyosa, Rajiv V Dave, Ama De-Graft Aikins, Helena M Earl, Beverley M Essue, Ruth B Etzioni, Sarah T Hawley, Xiaoxiao Jiang, Indraneel Mittra, Patricia I Moreno, Renu Sara Nargund, Cara Noble, Robert A Smith, Didier Verhoeven, Jiani N Wang, David A Watkins, Brian J Zikmund-Fisher
Publikováno v:
2022, ' The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge ', The Lancet, vol. 399, no. 10330, pp. 1101-1103 . https://doi.org/10.1016/S0140-6736(22)00184-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc7ab9cd7b30765d97443eeccc25a718
https://www.pure.ed.ac.uk/ws/files/250245693/lancet_breast_cancer_commission_launch_comment_v12.pdf
https://www.pure.ed.ac.uk/ws/files/250245693/lancet_breast_cancer_commission_launch_comment_v12.pdf
Autor:
Marc D. Ryser, Jane Lange, Lurdes Y.T. Inoue, Ellen S. O’Meara, Charlotte Gard, Diana L. Miglioretti, Jean-Luc Bulliard, Andrew F. Brouwer, E. Shelley Hwang, Ruth B. Etzioni
Publikováno v:
Annals of internal medicine, vol 175, iss 4
Ann Intern Med
Ann Intern Med
BACKGROUND: Mammography screening can lead to overdiagnosis—that is, screen-detected breast cancer that would not have caused symptoms or signs in the remaining lifetime. There is no consensus about the frequency of breast cancer overdiagnosis. OBJ
Publikováno v:
Value in Health. 24:S51-S52
The current COVID-19 pandemic is having a devastating impact on the world. As of May 8th, 2020, more than half of the world is in lockdown, 3.6 million people have been infected, and over 250,000 of them have died. This is the first pandemic in human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5241d1bede43e80a78ca6ed48f520eef
https://doi.org/10.1101/2020.05.21.20109298
https://doi.org/10.1101/2020.05.21.20109298
Autor:
Nathaniel Hendrix, Roman Gulati, Ruth B. Etzioni, Todd M. Morgan, John L. Gore, Michael W. Kattan, Boshen Jiao, J.J. Tosoian, Soroush Rais-Bahrami
Publikováno v:
Value in Health. 24:S50
Autor:
Sigrid Carlsson, Anna Bill-Axelson, Bruce J. Trock, Jane M. Lange, David F. Penson, Daniel W. Lin, Mathew R. Cooperberg, Ruth B. Etzioni, Janet E. Cowan, Aaron A. Laviana, Laurence Klotz, Peter R. Carroll, Lisa F. Newcomb, H. Ballentine Carter
Publikováno v:
Cancer. 126(3)
Background Active surveillance (AS) is an accepted means of managing low-risk prostate cancer. Because of the rarity of downstream events, data from existing AS cohorts cannot yet address how differences in surveillance intensity affect metastasis an
It is generally accepted that some screen-detected breast cancers are overdiagnosed and would not progress to symptomatic cancer if left untreated. However, precise estimates of the fraction of nonprogressive cancers remain elusive. In recognition of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc6d64ef08299e6229fd403e30b67e01
https://europepmc.org/articles/PMC6321806/
https://europepmc.org/articles/PMC6321806/